Profluent, spurred by Salesforce research and backed by Jeff Dean, uses AI to discover medicines | TechCrunch
Briefly

ProGen culminated in research published in the journal Nature Biotech showing that the AI could successfully create the 3D structures of artificial proteins.
Many drugs, like enzymes and antibodies, are composed of proteins, indicating potential AI-designed protein treatments for patients in the future.
Read at TechCrunch
[
add
]
[
|
|
]